Fundz
Real-time · AI · Cross-signal

Novartis just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Novartis, plus every contract, funding round, and exec hire that follows, each with verified, ICP-ranked contacts.

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Get the full Deep Dive on Novartis — free.

We'll email your report. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

▶
Watch the 2-minute tour · with sound

Novartis partners with Ratio Therapeutics for $745M radiopharma development

Nov 18, 2024•over 1 year ago

Contract Type

partnership

SwitzerlandBiotechnologyHealth Carepharmaceuticals

Description

Novartis has secured a partnership with radiopharmaceutical biotech Ratio Therapeutics to collaborate on the development of a cancer candidate. The partnership will utilize Ratio’s radioligand therapy discovery and development expertise to research a somatostatin receptor 2 (SSTR2) radiotherapeutic drug.

Company Information

Company

Novartis

Location

2 Fabrikstrasse

Switzerland

About

Novartis is a global healthcare company based in Switzerland. It is focused on developing innovative medicines to improve and extend people's lives. The company operates in various therapeutic areas, including oncology, cardiology, and immunology. Novartis is known for its commitment to research and development.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Novartis's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.